Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study

Journal of Neuroimmunology

Volumn 215, Issue 1-2, 2009, Pages 31-35

  Sabater, Lidia ^a   Giralt, Albert ^a   Boronat, Anna ^a   Hankiewicz, Karolina ^a   Blanco, Yolanda ^a   Llufriu, Sara ^a   Alberch, Jordi ^a   Graus, Francesc ^a   Saiz, Albert ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Apoptosis; Aquaporin 4; Cell death; Multiple sclerosis; Neuromyelitis optica; Neuromyelitis optica antibody (NMO IgG)

Indexed keywords

CASPASE 3; CASPASE 7; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES; APOPTOSIS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEUROMYELITIS OPTICA; YOUNG ADULT;

EID: 70349752929     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.07.014     Document Type: Article

References (23)

1. Cabrera-Gómez J., Saiz A., Graus F., González-Quevedo A., Rodriguez-Rojas R., Quevedo-Sotolongo L., Real-González Y., Grass-Fernández D., Cristófol-Corominas M., Rodriguez-Cordero M., Robinson-Agramonte M., Infante-Velázquez E., Cabrera-Núñez A., Ugarte-Sánchez C., Jordán-González J., González de la Nuez J., García-Lahera J., Tellez R., Baez-Martín M., and Romero-García K. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult. Scler. 14 (2008) 48-51
2. Hinson S.R., Pittock S.J., Lucchinetti C.F., Roemer S.F., Fryer J.P., Kryzer T.J., and Lennon V.A. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69 (2007) 2221-2231
3. Hinson S.R., Roemer S.F., Lucchinetti C.F., Fryer J.P., Kryzer J., Chamberlain L., Howe C.L., Pittock S.J., and Lennon V.A. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J. Exp. Med. 205 (2008) 2473-2481
4. Jarius S., Aboul-Enein F., Waters P., Kuenz B., Hauser A., Berger T., Lang W., Reindl M., Vincent A., and Kristoferitsch W. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131 (2008) 3072-3080
5. Kinoshita M., Nakatsuji Y., Moriya M., Okuno T., Kumanogoh A., Nakano M., Takahashi T., Fujihara K., Tanaka K., and Sakoda S. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. NeuroReport 20 (2009) 508-512
6. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., Hengartner M., Knight R.A., Lipton S.A., Maolorni W., Nuñez G., Peter M.E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., and Melino G. Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ. 16 (2009) 3-11
7. Lalive P.H., Menge T., Barman I., Cree B.A., and Genain C.P. Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 67 (2006) 176-177
8. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fuhijara K., Nakashima I., and Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
9. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202 (2005) 473-477
10. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuck D., Parisi J.E., and Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125 (2002) 1450-1461
11. Martín-Ibáñez R., Urbán N., Sergent-Tanguy S., Pineda J.R., Garrido-Clua N., Alberch J., and Canals J.M. Interplay of leukemia inhibitory factor and retinoic acid on neural differentiation of mouse embryonic stem cells. J. Neurosci. Res. 85 (2007) 2686-2701
12. Matiello M., Lennon V.A., Jacob A., Pittock S.J., Lucchinetti C.F., Wingerchuk D.M., and Weinshenker B.G. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70 (2008) 2179-2200
13. McCarthy K.D., and de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell. Bio. 85 (1980) 890-902
14. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wolheim M., Sibley W., Thompson A., Weinshenker B., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
15. Misu T., Fujihara K., Kakitja A., Konno H., Nakamura M., Watanabe S., Takahashi T., Nakashima I., Takahashi H., and Itoyama Y. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130 (2007) 1224-1234
16. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassman H., Bruck W., Mandler R.N., Weinshenker B.G., Pittock S.J., Wingerchuck D.M., and Lucchimetti C.F. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130 (2007) 1194-1205
17. Saiz A., Zuliani L., Blanco Y., Tavolato B., Giometto B., Graus F., and Spanish-Italian NMO study group. Revised diagnostic criteria for neuromyelitis optica (NMO): application in a series of suspected patients. J. Neurol. 254 (2007) 1233-1237
18. Vincent T., Saikali P., Cayrol R., Roth A.D., Bar-Or A., Prat A., and Antel J.P. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J. Immunol. 181 (2008) 5730-5737
19. Waters P., and Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int. MS J. 15 (2008) 99-105
20. Waters P., Jarius S., Littleton E., Leite M.I., Jacob S., Gray B., Geraldes R., Vale T., Jacob A., Palace J., Maxwell S., Beeson D., and Vincent A. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch. Neurol. 65 (2008) 913-919
21. Weinshenker B.G., Wingerchuk D.M., Vukusic S., Linbo L., Pittock S.J., Lucchinetti C.F., and Lennon V.A. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 59 (2006) 566-569
22. Whitney K.D., and McNamara J.O. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J. Neurosci. 20 (2000) 7307-7316
23. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., and Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66 (2006) 1485-1489